Literature DB >> 1856697

The 36K polypeptide synthesized in Newcastle disease virus-infected cells possesses properties predicted for the hypothesized 'V' protein.

A C Samson1, I Levesley, P H Russell.   

Abstract

Newcastle disease virus (NDV) virions possess two proteins which react strongly with monoclonal antibody 688 following separation by high resolution two-dimensional (isoelectric focusing/SDS) PAGE and detection by Western blotting. One is the phosphorylated nucleocapsid-associated 53K [P (NAP)] protein, the other comigrates with the 36K protein detected by radiolabelling NDV-infected chick embryo fibroblasts. [35S]Cysteine/[3H]leucine dual-labelling experiments show that the 36K protein is very rich in cysteine compared to the P (NAP) protein. In the Beaudette C strain it comigrates on one-dimensional SDS-polyacrylamide gels with the matrix protein (M); however, it is resolved from the slower migrating M protein from the Ulster strain of NDV. The size, strain-specific isoelectric point, high cysteine content and antigenic relatedness to the P (NAP) protein suggest that the 36K protein is the 'V' protein of NDV, the counterpart of which is found in other Paramyxoviridae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856697     DOI: 10.1099/0022-1317-72-7-1709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Nucleotide sequence of the phosphoprotein (P) gene of Newcastle disease virus (strain Beaudette C).

Authors:  S Daskalakis; J Menke; B Stripp; H Stone
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

3.  In vitro transcription and replication of the mumps virus genome.

Authors:  K Takeuchi; K Tanabayashi; K Okazaki; M Hiahiyama; A Yamada
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos.

Authors:  T Mebatsion; S Verstegen; L T De Vaan; A Römer-Oberdörfer; C C Schrier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  The Newcastle disease virus V protein binds zinc.

Authors:  M Steward; A C Samson; W Errington; P T Emmerson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Newcastle disease virus V protein is a determinant of host range restriction.

Authors:  Man-Seong Park; Adolfo García-Sastre; Jerome F Cros; Christopher F Basler; Peter Palese
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.

Authors:  Zhuhui Huang; Sateesh Krishnamurthy; Aruna Panda; Siba K Samal
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Rescue of virulent class I Newcastle disease virus variant 9a5b-D5C1.

Authors:  Yang Yu; Xusheng Qiu; Dan Xu; Yuan Zhan; Chunchun Meng; Nana Wei; Hongjun Chen; Lei Tan; Shengqing Yu; Xiufan Liu; Aijian Qin; Chan Ding
Journal:  Virol J       Date:  2012-06-18       Impact factor: 4.099

9.  Entire genome sequence analysis of genotype IX Newcastle disease viruses reveals their early-genotype phylogenetic position and recent-genotype genome size.

Authors:  Xusheng Qiu; Qing Sun; Shuang Wu; Li Dong; Shunling Hu; Chunchun Meng; Yantao Wu; Xiufan Liu
Journal:  Virol J       Date:  2011-03-14       Impact factor: 4.099

10.  Development of strand-specific real-time RT-PCR to distinguish viral RNAs during Newcastle disease virus infection.

Authors:  Xusheng Qiu; Yang Yu; Shengqing Yu; Yuan Zhan; Nana Wei; Cuiping Song; Yingjie Sun; Lei Tan; Chan Ding
Journal:  ScientificWorldJournal       Date:  2014-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.